1. Reversible modifications of brain neurotransmitters in experimental acute hepatic coma;Bloch, P.; Delorme, M.L.; Rapin, J.R.; Boschat, M.; Opolon, P.;Surgery, Gynecology and Obstetrics,1978
2. Effect of insulin and glucagon on fulminant murine hepatitis;Farivar, M.; Wands, J.R.; Isselbacher, K.J.; Bucher, N.L.R.;New England Journal of Medicine,1976
3. Pathogenesis and therapy of hepatic coma;Fischer, J.E.; Baldessarini, R.J.;Progress in Liver Diseases,1976
4. The role of plasma amino-acids in hepatic encephalopathy;Fischer, J.E.; Funovics, J.M.; Aguirre, A.; James, J.H.; Keane, J.M.; Wesdorp, R.I.C.; Yoshimnura, N.; Westman, T.;Surgery,1975
5. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage;Gazzard, B.G.; Portmann, B.; Murray-Lyon, I.M.; Williams, R.;Quarterly Journal of Medicine,1975